ZA93549B - Azabicyclo compounds as calcium channel antagonists - Google Patents
Azabicyclo compounds as calcium channel antagonistsInfo
- Publication number
- ZA93549B ZA93549B ZA93549A ZA93549A ZA93549B ZA 93549 B ZA93549 B ZA 93549B ZA 93549 A ZA93549 A ZA 93549A ZA 93549 A ZA93549 A ZA 93549A ZA 93549 B ZA93549 B ZA 93549B
- Authority
- ZA
- South Africa
- Prior art keywords
- calcium channel
- channel antagonists
- azabicyclo compounds
- azabicyclo
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929201751A GB9201751D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA93549B true ZA93549B (en) | 1994-09-22 |
Family
ID=10709351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA93549A ZA93549B (en) | 1992-01-28 | 1993-01-26 | Azabicyclo compounds as calcium channel antagonists |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0625981A1 (de) |
JP (1) | JPH07503462A (de) |
KR (1) | KR950700305A (de) |
AU (1) | AU3364593A (de) |
CA (1) | CA2128536A1 (de) |
GB (1) | GB9201751D0 (de) |
MX (1) | MX9300406A (de) |
WO (1) | WO1993015080A1 (de) |
ZA (1) | ZA93549B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9314973D0 (en) * | 1993-07-20 | 1993-09-01 | Smithkline Beecham Plc | Medicaments |
UY25225A1 (es) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
AU1600599A (en) | 1998-02-27 | 1999-09-15 | Warner-Lambert Company | Heterocyclic substituted aniline calcium channel blockers |
US6166052A (en) * | 1998-03-11 | 2000-12-26 | Warner-Lambert Company | Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
EP1345937B1 (de) | 2000-12-22 | 2005-09-28 | Almirall Prodesfarma AG | Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten |
ES2203327B1 (es) | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
ES2204295B1 (es) | 2002-07-02 | 2005-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de quinuclidina-amida. |
EP2217597B1 (de) | 2007-10-01 | 2011-03-30 | Comentis, Inc. | 1h-indol-3-carbonsäure-chinuclidin-4-ylmethylesterderivate als liganden für den nikotinischen alpha-7-acetylcholinrezeptor zur behandlung von alzheimer-krankheit |
JP2017524736A (ja) | 2014-07-11 | 2017-08-31 | アルファーマゲン,エルエルシー | アルファ7−ニコチン性アセチルコリン受容体活性を調節するためのキヌクリジン化合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1250534A (de) * | 1969-03-03 | 1971-10-20 | ||
GB9005737D0 (en) * | 1990-03-14 | 1990-05-09 | Beecham Group Plc | Novel compounds |
-
1992
- 1992-01-28 GB GB929201751A patent/GB9201751D0/en active Pending
-
1993
- 1993-01-26 MX MX9300406A patent/MX9300406A/es unknown
- 1993-01-26 ZA ZA93549A patent/ZA93549B/xx unknown
- 1993-01-27 CA CA002128536A patent/CA2128536A1/en not_active Abandoned
- 1993-01-27 AU AU33645/93A patent/AU3364593A/en not_active Abandoned
- 1993-01-27 JP JP5513048A patent/JPH07503462A/ja active Pending
- 1993-01-27 EP EP93902470A patent/EP0625981A1/de not_active Withdrawn
- 1993-01-27 WO PCT/GB1993/000174 patent/WO1993015080A1/en not_active Application Discontinuation
-
1994
- 1994-07-27 KR KR1019940702589A patent/KR950700305A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1993015080A1 (en) | 1993-08-05 |
AU3364593A (en) | 1993-09-01 |
CA2128536A1 (en) | 1993-08-05 |
GB9201751D0 (en) | 1992-03-11 |
EP0625981A1 (de) | 1994-11-30 |
KR950700305A (ko) | 1995-01-16 |
JPH07503462A (ja) | 1995-04-13 |
MX9300406A (es) | 1994-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA93550B (en) | Azabricyclic compounds as calcium channel antagonists | |
GB9315962D0 (en) | Azabicyclic compounds | |
AU3364493A (en) | Compounds as calcium channel antagonists | |
AP9300562A0 (en) | Novel compounds | |
ZA93549B (en) | Azabicyclo compounds as calcium channel antagonists | |
GB9202779D0 (en) | Novel compounds | |
ZA948232B (en) | Amine derivatives as calcium channel antagonists | |
GB9203476D0 (en) | Novel compounds | |
EP0465191A3 (en) | Bicyclic sulfur-containing compounds | |
GB9220893D0 (en) | Azabicyclo compounds | |
GB9208133D0 (en) | Azabicyclo compounds | |
ZA939514B (en) | Piperidine derivatives as calcium channel antagonists | |
GB9303720D0 (en) | Azabicyclo compounds | |
IE900471L (en) | Calcium antagonists | |
ZA975446B (en) | Substituted azabicyclic compounds | |
GB9201483D0 (en) | Novel compounds | |
GB9202931D0 (en) | Novel compounds | |
GB9200712D0 (en) | Novel compounds | |
GB9201290D0 (en) | Novel compounds | |
GB9201291D0 (en) | Novel compounds | |
GB9201413D0 (en) | Novel compounds | |
GB9204996D0 (en) | Novel compounds | |
GB9201506D0 (en) | Novel compounds | |
GB9201507D0 (en) | Novel compounds | |
GB9201957D0 (en) | Novel compounds |